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Summary 
The X-ray structure of the ternary complex of a cal- 
cineurin A fragment, calcineurin B, FKBP12, and the 
immunosuppreseant drug FK506 (also known as tac- 
rolimus) has been determined at 2.5 .~ resolution, pro- 
viding a description of how FK506 functions at the 
atomic level. In the structure, the FKBP12-FK506 bi- 
nary complex does not contact the phosphatase active 
site on calcineurin A that is more than 10 A removed. 
Instead, FKBP12-FK506 is so positioned that it can 
inhibit the dephosphorylation of its macromolecular 
substrates by physically hindering their approach to 
the active site. The ternary complex described here 
represents the three-dimensional structure of a Ser/Thr 
protein phosphatase and provides a structural basis for 
understanding calcineurin inhibition by FKBP12-FK506. 
Introduction 
Following presentation of antigen to the T cell receptor, 
a cascade of signal transduction events is initiated that 
ultimately leads to lymphokine gene expression and T cell 
proliferation (Crabtree, 1989). Early events associated 
with this process include an increase in the levels of intra- 
cellular Ca 2÷ and the activation of protein kinase C, which 
together stimulate transcription of early genes in the T cell 
activation process, such as interleukin-2 (IL-2), IL-3, IL-4, 
granulocyte/macrophage colony-stimulating factor, and 
interferon-y (reviewed by Crabtree and Clipstone, 1994). 
The therapeutic relevance of this pathway was ascertained 
as a consequence of the discovery of cyclosporin A (CsA; 
Borel et al., 1976) and later of FK506 (also known as tacroli- 
mus; Kino et al., 1987), macrocyclic natural products (Fig- 
ure 1) that exert their inhibitory effects by blocking steps 
in the T cell activation pathway that are downstream of 
intracellular Ca 2+ release and protein kinase C activation 
(Tocci et al., 1989; Emmel et al., 1989). These two com- 
pounds have been approved as drugs for the prevention 
of graft rejection following organ transplantation and in 
the treatment of certain autoimmune disorders (reviewed 
by Borel, 1989; DiPadova, 1994). 
Calcineurin (also referred to as protein phosphatase 2B 
[PP2B]) is a Ser/Thr PPase whose activity is strongly stim- 
ulated by the presence of Ca 2÷ and calmodulin (CAM) (Klee 
et al., 1988) as part of its essential role in the T cell activa- 
tion pathway (O'Keefe et al., 1992; Clipstone and Crabtree, 
1992). Although the in vivo target of caicineurin in T cells 
has not yet been verified, in vitro studies strongly suggest 
that one target is the nuclear factor of activated transcrip- 
tion (NF-ATp) (McCaffrey et al., 1993). NF-ATp is a lympho- 
cyte-specific transcription factor that translocates from the 
cytoplasm to the nucleus following intracellular Ca 2÷ re- 
lease (Flanagan et al., 1991). Translocation of NF-ATp to 
the nucleus correlates with its dephosphorylation, presum- 
ably by Ca2÷/CaM-stimulated calcineurin. Once in the nu- 
cleus, NF-ATp binds to the promoter of the 11_-2 gene and, 
in concert with other transcription factors, stimulates ex- 
pression of this early gene in the T cell activation pathway 
(Northrup et al., 1993; McCaffrey et al., 1993; Jain et al., 
1993). 
A wealth of biochemical data now exists that defines 
calcineurin as the immunosuppressive target of FK506 and 
CsA (Liu et al., 1991; O'Keefe et al., 1992; Clipstone and 
Crabtree, 1992). Both of these compounds inhibit calcineurin 
in association with their major cellular-binding proteins, 
FKBP12 and cyclophilin (CyP), respectively. FKBP12 and 
CyP are small, ubiquitous cytosolic proteins that function 
enzymatically as cis-trans peptidyl prolyl isomerases. 
Both enzymes are strongly inhibited upon binding of their 
cognate ligands, but this inhibition is not sufficient o block 
T cell signaling (Heitman et al., 1991; Koltin et al., 1991). 
Instead, these immunophilin-immunosuppresant com- 
plexes (FKBP12-FK506 and CyP-CsA) suppress T cell 
activation by binding to calcineurin and inhibiting its phos- 
phatase activity (Liu et al., 1991; O'Keefe et al., 1992; 
Clipstone and Crabtree, 1992). Calcineurin inhibition by 
FKBP12-FKS06 or by CyP-CsA correlates with their abii- 
ityto inhibit IL-2 production in T cells (Fruman et al., 1992), 
a critical step in T cell proliferation. 
Calcineurin is also of considerable interest because it 
is a member of the Ser/l-hr PPase family of enzymes, 
for which limited structural information exists. Calcineurin 
shares high sequence homology with two other members 
of the Ser/Thr PPase family, PP1 and PP2A (Ito et al., 
1989). In addition, calcineurin displays Ca2÷/CaM depen- 
dence, which makes it unique among this family of phos- 
phatases (Klee et al., 1988; Kincaid et al., 1988). Calci- 
neurin consists of two tightly associated subunits: a 60 
kDa catalytic subunit (calcineurin A [CnA]) and a 19 kDa 
regulatory subunit (calcineurin B [CnB]). The CnA subunit 
shares high sequence homology with PP1 and PP2A, 
while CnB contains four putative EF hand Ca2+-binding 
sites (Kretsinger and Nockolds, 1973), similar to those 
found in CaM (Babu et al., 1988). Compared with PP1 and 
PP2A, however, CnA contains an extra 170 residues at 
its C-terminus (Ito et al., 1989). This sequence has been 
shown to contain the CnB-binding domain (Guerini and 
Klee, 1989; Sikkink et al., 1995), a CaM-binding domain 
(Hashimoto et al., 1990), and an autoinhibitory domain 
(AID) (Flanagan et al., 1991), all of which are involved in 
regulating calcineurin phosphatase activity. 
To understand better the mechanism of calcineurin 
phosphatase activity, the inhibition of calcineurin by 
FKBP12-FKS06, and the regulation of this enzyme by as- 
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Figure 1. Chemical Structures of FK506 and 
Rapamycin 
The corresponding differences in chemical 
structures of the effector domains of FK506 (A) 
and rapamycin (B) were at one point believed 
to be largely responsible for differentiating the 
calcineurin inhibitory agonist activity of FK506 
from the antagonist activity of rapamycin. The 
effector domains roughly include backbone 
atoms and substit uents at C18-C23 in the mac- 
recycle and at C26-C34 in the cyclohexyl ring 
for FK506 and, equivalently, C15-C27 and 
C34-C42 for rapamycin. R~ = -CH2CHCH2; R2, 
R3 = -H. 
sociation with other proteins, we have solved the crystal 
structure at 2.5 ,&. resolution of a ternary complex con- 
taining the phosphatase and CnB-binding regions of CnA, 
CnB, and FKBP12-FK506. The structure reported here. 
provides a detailed view of an immunophilin-immunosup- 
pressant complex inhibiting its cellular target and charac- 
terizes the FKBP12-FK506 composite surface that is nec- 
essary for calcineurin binding. In so doing, it addresses 
and resolves much of the speculation that has surrounded 
this critical event in immunosuppression. This study also 
provides the three-dimensional structure of an important 
class of enzymes in signal transduction pathways, the Ser/ 
Thr PPases. 
Results 
Architecture of the Ternary Complex 
The components of the ternary complex associate to form 
a roughly rectangular structure with overall dimensions of 
87 ,~ x 61 ~, x 37 ,~, (Figure 2). The largest component 
is a proteolytic fragment of CnA (residues 17-392) that 
incorporates the phosphatase catalytic domain and the 
CnB-binding region; missing from the CnA fragment in the 
structure are the CaM-binding and autoinhibitory regions. 
The globular CnA phosphatase domain is characterized 
by a 13-sandwich motif that forms the core of the enzyme. 
This motif is seen in other proteins uch as DNase I (Oefner 
and Suck, 1986) and exonuclease III (Mol et al., 1995), 
but the degree of structural similarity to CnA is limited. 
Perhaps the most striking feature of the ternary complex, 
however, is the 22 residue CnB-binding ~ helix (BBH) that 
extends nearly 40,~ away from the surface of the phospha- 
tase domain and is connected to it by a short linker se- 
quence. The CnB component of the ternary complex in- 
cludes two CaM-like domains that form a hydrophobic 
groove that grasps the upper surface of the BBH. The 
underside of the BBH remains completely exposed (Figure 
2), and it is to this exposed region of the BBH that the 
FKBP12-FK506 complex binds. Interestingly, the calci- 
neurin active site, which is located on the surface of the 
phosphatase domain, is not in contact with any other corn- 
ponent of the ternary complex; its nearest neighbor, 
FKBP12, is more than 10 ,~ removed. 
Architecture of CnA: The Phosphatase Domain 
The phosphatase domain of CnA forms an ellipsoid ap- 
proximately 35 ~, × 35 ,~, x 45 ,~, in size. The core of the 
domain consists of two mixed 13 sheets, termed sheet 1 
and sheet 2, that are flanked on one side by a mixed a/[~ 
structure and on the other side by an all ~ structure (Figure 
3). The two central 9 sheets form a distorted 13 sandwich 
that contains an open and closed end. At the closed end 
of the 13 sandwich, sheet 2 extends above sheet 1, resem- 
bling the Greek letter X, with a separation angle between 
the sheets of approximately 30 ° . The inner core of the 
sandwich is populated with hydrophobic residues: smaller 
side chains at the closed end of the core and larger ones 
at the open end. Strands 96, ~10, and 1312 from sheet 1 
are parallel and run in the direction of the closed end of 
the sandwich, as do strands 134, 93, 92, and 1514 in sheet 
2. Following 1514, the sequence forms an extended region 
of approximately 24 residues that connects to the BBH. 
Residues 340-348, while still part of the phosphatase 
core, also participate in multiple contacts with CnB and 
can be considered part of the CnB-binding region. Addi- 
tional contacts between CnA and CnB occur at the N-ter- 
minus of CnA and in loop L1, where a salt bridge is formed 
between Glu-53 of CnA and Lys-134 of CnB. These inter- 
actions appear to help stabilize the extended CnB-BBH 
structure. 
The phosphatase active site is located above the closed 
end of the 13 sandwich, formed by the convergence of sev- 
eral loops and by that portion of sheet 2 that extends above 
the 15 sandwich (Figures 2 and 3). Active site residues 
are found in loops L2, L3, L4, and L6 and at the C-termini 
of strands 152 and 93. The somewhat shallow active site 
pocket is located in the middle of a larger, curved channel 
that runs along the top of sheet 1 and helix ~9 (Figures 
3 and 4). This channel should accommodate access by 
larger phosphorylated substrates to the active site and 
may help provide specificity through interactions with resi- 
dues surrounding the phosphorylated side chain of the 
Calcineurin Inhibition by FKBP12-FK506 
509 
Figure 2. Overall Architecture of the Calcineurin Ternary Complex in Stereo 
(A) Solvent accessible surface of the ternary complex, with its individual components color coded throughout as follows: CnA in blue, CnB in 
green, FKBP12 in red, and FK506 in white. (B) Ribbon diagram of the ternary complex. (C) Exploded view of the ternary complex in a space-filling 
representation, showing FK5O6 bound to the BBH of CnA. The bound phosphate in the phosphatase active site of CnA is shown in yellow; the 
myristate posttranslational modification li ked to the N-terminal glycine of CnB is shown in purple. These figures were generated using the program 
VOXSHADE (J. P. G., unpublished data). 
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Figure 3. Structure of Calcineurin 
(A) Sequence of bovine CnA. (B) Sequence of bovine 
CnB. A detailed discusion of the determination of the 
sequence of bovine brain CnA will be described else- 
where (K. H. and M. Su, unpublished data). The se- 
quence of bovine CnB is taken from Nargang et al. 
(1994). In both cases, secondary structural elements 
are indicated above the sequence. The CnA ligands 
to the two metals are indicated by an asterisk below 
the sequence. The N-terminal and C-terminal residues 
that were removed by proteolysis prior to crystallization 
are shown in lower case; these include the CaM- 
binding domain and AID of CnA. Residues shown in 
italics are not clearly visible in the electron density 
maps and are presumably disordered. (C) Ribbon dia- 
gram of the phosphatase domain of C nA in stereo. The 
two central 13 sheets form a distorted ![3 sandwich, with 
sheet 1 consisting of six ~ strands (in the order 131- 
,B5-[36-~10-~12-~11) and sheet 2 consisting of five i3 
strands (in the order 134-133-~2-~13-1314). The surface 
of sheet 1 is covered by three (~ helixes and a three- 
stranded 13 sheet while sheet 2 is covered by an all 
a-helical structure. The active site is located at the 
closed end of the 13 sandwich, corresponding to the 
two metal ions shown as spheres, and the bound phos- 
phate in ball-and-stick format. This figure was gener- 
ated using the program RIBBONS (Carson, 1991). 
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Figure 4. The Phosphatase Active Site on CnA 
(A) The refined coordinates of the active site are superimposed on the corresponding 2Fo-Fc electron density map (contoured at 4.0 s). Atoms 
are color coded by element ype: carbon in green, nitrogen in blue, oxygen in red, and phosphorus in yellow. (B) Coordination spheres of the two 
metals: Fe 3÷ (shown in cyan) and Zn 2÷ (shown in yellow). Coordination is represented by broken lines. Phosphorus is shown in purple. (C) Solvent 
accessible surface of the active site. (B) and (C) were generated using the program VOXSHADE. The phosphate is shown in yellow ball-and-stick 
format. The same rough orientation is used in all three figures. 
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substrate. The broad, shallow active site is also consistent 
with observations that other SerFFhr PPases are able to 
catalyze the dephosphorylation of certain phosphotyro- 
sine substrates as well as their natural substrates (Donella- 
Deana et al., 1994). 
The active site (Figure 4) contains two metal ion sites 
that are modeled as Zn 2+ and Fe 3÷, in addition to a single 
phosphate ion, whose presence in the structure may be 
the result of including 100 mM potassium phosphate buffer 
in the crystallization conditions. The assignment of these 
two metals in the active site is consistent with atomic ab- 
sorption experiments that found stoichiometric amounts 
of Zn 2÷ and Fe 3÷ in CnA (King and Huang, 1984). It is also 
in agreement with the crystal structure of purple acid phos- 
phatase (PAP), which also includes a Zn2+/Fe 3÷ pair in its 
active site (Strater et al., 1995) and appears to be similar 
to calcineurin in this region. The Zn 2÷ and Fe 3÷ atoms are 
identified as such on the basis of their interactions with 
surrounding ligands and are separated by 3.0 ,&. in the 
active site. The Zn 2÷ is coordinated by the side chains 
Asp-118 (O52), Asn-150 (O51), His-199 (N~2), a.nd His-281 
(N81) and by a phosphate oxygen. This coordination 
sphere is identical to that of the Zn 2+ in PAP except for the 
phosphate, which is not present in that structure (Strater et 
al., 1995). The Fe 3÷ is coordinated by Asp-90 (O51), His-92 
(N~2), Asp-118 (O~52), a phosphate oxygen, and a water 
molecule. In the PAP structure, a Tyr and a His substitute 
for His-92 and the water in CnA, respectively, with the 
other ligands remaining the same. In both structures an 
Asp side chain acts as a monodentate bridging ligand be- 
tween the metals (Asp-118 in CnA versus Asp-164 in PAP). 
In the current model, the preferred octahedral coordina- 
tion for Fe 3+ would be fully satisfied by a single bridging 
ligand, possibly a water or OH-, opposite the bridging oxy- 
gen of Asp-118 (Figure 4B). At this stage of refinement, 
however, and in the vicinity of two metal ions, it is difficult 
to assign electron density to this bridging water molecule 
with any confidence. A similar bridging OH- ligand was 
modeled into the Zn2+/Fe 3÷ metal cluster of PAP (Strater 
et al., 1995), along with two nonbridging ligands that would 
be represented by the phosphate oxygens in our structure. 
In the calcineurin ternary complex, a bridging water mole- 
cule can be modeled to be within 2.9 ,&, of the phosphorous 
atom and colinear with one of the P-O bonds, a geometry 
that is favorable for nucleophilic attack on the phospho- 
rous. This water would also be stabilized by its interaction 
with the carbonyl oxygen of His-281. 
In addition to coordinating both metals, the bound phos- 
phate in the active site is stabilized by interactions with 
the guanidinium groups of Arg-122 and Arg-254 and with 
the N~2 of His-151. Arg-254 is stabilized through a biden- 
tate interaction with the carboxylate of Asp-234, as it ex- 
tends into the active site from loop L5, which is 8.5 ~. 
away from the phosphate. In turn, His-151 is situated in 
the active site, within hydrogen bonding distance of the 
most solvent-exposed oxygen of the bound phosphate. 
This could represent the leaving oxygen of the substrate 
based on its location opposite the putative water/OH- li- 
gand. Within this constellation, His-151 serves as a proton 
donor to the leaving group on the Ser side chain in an 
SN2-type mechanism. The His-151 side chain is stabilized 
by a hydrogen bond to Asp-121, with the main chain con- 
formation stabilized by the next residue, Glu-152, which 
makes a pair of hydrogen bonds to main chain nitrogens 
surrounding the metal-bridging ligand, Asp-118. 
BBH 
The BBH is a five-turn amphipathic ~ helix (residues 350- 
370) to which both CnB and the binary FKBP12-FK506 
,complex bind (Figure 5). The top half of the BBH is com- 
pletely nonpolar and forms a complementary surface for 
the hydrophobic groove formed by CnB (see below). The 
solvent accessible surface area lost by the BBH upon CnB 
binding is 1410 ,&2, which leaves 920 ,~2 solvent accessible 
surface area remaining. The tip of the BBH abuts the N-ter- 
minal helix of CnB, which lies perpendicular to the axis 
of BBH and caps the end of the BBH-binding groove. The 
lower half of the BBH is polar except for a small hydropho- 
bic patch near its N-terminus. This patch forms the contact 
surface with the FKBP12-FK506 complex. 
Architecture of CnB 
The structure of CnB consists of two globular Ca2+-binding 
domains flanked by a long C-terminal ~ strand. Each Ca 2÷- 
binding domain contains two Ca2+-binding EF hand motifs. 
Domain 1 (residues 1-84) connects to domain 2 (residues 
86-155) via an ~ helix that is kinked at Gly-85. Domains 
1 and 2 are arranged linearly along the BBH and, together 
with the amphipathic C-terminal strand, form a 33 A long 
hydrophobic groove into which the top half of the BBH is 
embedded (Figure 5). The two CnB domains can be approxi- 
mately superimposed by a translation of 22 ~. along the 
BBH. This arrangement of Ca2+-binding domains on an a 
helix is in contrast with the way CaM binds to ~ helices. 
For example, the nuclear magnetic resonance (NMR) 
structure of CaM bound to light chain myosin (Ikura et al., 
1992) shows the two CaM domains arranged on opposite 
sides of an ~ helix and related by a 2-fold rotation (Figure 
6). A similar domain relationship can be seen in the X-ray 
structure of CaM complexed with the CaM-binding domain 
of the CaM-dependent protein kinase II (Meador et al., 
1992). 
The three-dimensional structure of each of the pairs of 
EF hands (EF1 and EF2 in domain 1 and EF3 and EF4 
in domain 2) in CnB is highly conserved with those of other 
members of the superfamily; the intradomain Ca2+-Ca 2÷ 
distances in CnB are nearly identical to those found in 
CaM, for example. In all four EF hands, Ca 2+ is coordinated 
by five ligands. These are Asp-30, Asp-32, Ser-34, Glu-41, 
and the Ser-36 carbonyl for EF1 ; Asp-62, Asp-64, Asn-66, 
Glu-73, and the Gly-68 carbonyl for EF2; Asp-99, Asp-101, 
Asp-103, Glu-110, and Tyr-105 carbonyl for EF3; and Asp- 
140, Asp-142, Asp-144, Glu-151, and Arg-146 carbonyl for 
EF4. This suggests that all four sites are high affinity Ca 2+ 
sites and is consistent with the electron density maps, 
which show all four to be equally occupied, and with NMR 
observations made by Kakalis et al. (1995). 
The N-terminal glycine of CnB is covalently linked to 
myristate, a 14-carbon saturated fatty acid. The myristate 
group is located at the extreme end of the calcineurin com- 
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Figure 5. Interaction ofCnB with the BBH of CnA 
Electrostatic potential surface of CriB generated with the program VOXSHADE. The BBH (residues 350-370 of CnA) is shown in ball-and-stick 
format, colored yellow. (A) The hydrophobic binding pocket of CnB that associates with the BBH. The solvent accessible surface area lost by CnB 
upon binding of CnA is 1681 A 2`  The protein surface is color coded according to its electrostatic potential, ranging from blue (most positive), to 
white (uncharged), and to red (most negative). (B) The same region rotated by 180 ° to display the polar outer surface. 
plex, near the end of the BBH (see Figure 2). It is connected 
to the N-terminal helix of CnB by a 15 residue loop and 
lays against and runs parallel to that helix, which is itself 
hydrophobic (Figure 7). Myristylation, a posttranslational 
modification, isoften discussed in the context of anchoring 
proteins to membranes (Resh, 1994), though it can also 
serve as a stabilizing structural element in a protein (Ames 
et al., 1995). 
Structure of FKBP12-FK506 
The conformation of FKBP12 in the ternary complex is nearly 
identical to that found in the structure of the FKBP12-FK506 
binary complex (van Duyne et al., 1991a; Becker et al., 
1993; Wilson et al., 1995). Superposition of FKBP12 from 
the ternary and binary complexes gives a root-mean- 
square (rms) deviation of 0.59 ,~ for Ca atoms. Similarly, 
the conformations of FK506 are almost identical in the 
two complexes, with an rms difference of 0.21 ,~ for all 
nonhydrogen atoms, excluding those from the highly flexi- 
ble C21 allyl group. However, the relative position of 
FK506 to FKBP12 differs in the ternary and binary com- 
plexes, as can be seen in Figure 7, which shows a superim- 
position of FKBP12 molecules from the two complexes. 
In the ternary complex, FK506 is rotated by about 8 ° from 
the body of FKBP12, resulting in a displacement of 1.7 ~, 
for the C21 carbon at the base of the allyl group. A concom- 
itant displacement of the His-87 to lie-90 loop in FKBP12 
is observed as well. This rotation allows the allyl and, to 
a lesser extent, cyclohexyl moieties of FK506 (see Figure 
1) to contact the BBH more intimately. One consequence 
of this rotation is the loss of a hydrogen bond between the  
Glu-54 carbonyl oxygen of FKBP12 and the C24 hydroxyl 
group of FK506 in the ternary complex. 
FKBP12-FK506 Binding to Calcineurin 
The FKBP12-FK506 complex binds to calcineurin at the 
base of the BBH, making contacts with the BBH, CnB, 
and the phosphatase domain of CnA (Figures 2, 7, and 
8). The solvent accessible surface area lost to each com- 
ponent upon FKBP12-FK506 binding is 320 ,~,2, 479 ~,2, 
and 512 ~2. FKBP12-calcineurin contacts surround the 
FK506 ligand and cluster to three distinct regions of the 
FKBP12 sequence: His-87 to lie-90, Asp-37 to Asp-41, and 
Arg-42 to Phe-46. These regions contact he BBH, the 
phosphatase domain, and CnB, respectively (Figures 7 
and 8). Several of these residues, including Asp-37, Arg- 
42, His-87, and lie-90, had previously been identified 
as mediators of calcineurin binding by FKBP12-FK506 
through site-directed mutagenesis experiments (Aldape 
et al., 1992; Yang et al., 1993; Futer et al., 1995). 
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Figure 6. Binding of CnB and CaM to Their Re- 
spective Target Helices 
(A) Binding of CnB to the BBH of CnA. (B) Bind- 
ing of CaM to its target helix on the CaM- 
dependent protein kinase Ila (PDB code 2BBM; 
Ikura et al., 1992). The binding of CnB to the 
BBH (residues 350-370 of CnA) involves a 
side-by-side interaction; in turn, CaM wraps 
around its target helix. Both CnB and CaM are 
shown in blue, while the target helices are 
shown in green. In both cases, a hydrophobic 
channel formed as a consequence of binding. 
The structures are rotated by 90 ° on the right 
to show the channel. 
The principal site of interaction between FK506 and cal- 
cineurin is a predominantly hydrophobic cleft located at 
the interface of CnB and the BBH. Side chains that form 
the cleft come from residues Leu-343, Pro-344, Trp-352, 
Ser-353 (CI3), and Phe-356 on the BBH and residues Leu- 
115, Met-118, Va1-119, and Leu-123 from CnB. This bind- 
ing cleft is approximately 8 ,~ long and has surface proper- 
ties complementary to the C15-C21 region of FK506. The 
majority of contacts made by FK506 are from C15-C17 
and the C21 allyl group. The allyl group extends into a 
deep pocket within the hydrophobic left, making a number 
of favorable van der Waals contacts with main chain and side 
chain atoms. The FK506-calcineurin interaction is further 
stabilized by an unusual bifurcated hydrogen bond between 
the N~I of Trp-352 and the C13 and C15 methoxy oxygens 
of FK506. 
Discussion 
Protein phosphorylation and dephosphorylation regulate 
a multitude of cellular processes, and an understanding 
of these events has been the focus of intensive research 
(Cohen, 1989; Hunter, 1995, and references therein). The 
Ser/Thr PPase family of enzymes are important partici- 
pants in these regulatory processes (reviewed by Cohen 
and Cohen, 1989; Shenolikar, 1994). The recent discovery 
that calcineurin is a major cellular target of immunosup- 
pressive drugs such as FK506 and CsA (Liu et al., 1991; 
O'Keefe et al., 1992; Clipstone and Crabtree, 1992) has 
prompted attempts at further characterization of this key 
component of the T cell activation pathway. The ternary com- 
plex described here presents not only the three-dimensional 
structure of a Ser/Thr PPase, but also a detailed view of an 
immunophilin-immunosuppressant complex inhibiting its 
cellular target. 
CnA as a Ser/Thr Phosphatase 
Mammalian CnA sequences are strongly homologous, 
typically displaying greater than 90% identity (Kincaid et 
al., 1990; Ito et al., 1989). CnA also shares over 40% se- 
quence identity (60% sequence conservation) with two 
other members of the Ser/Thr PPase family, PP1 and 
PP2A (Ito et al., 1989). Mapping the sequences of these 
Ser/Thr PPases onto the CnA structure (E. E. K., unpub- 
lished data) suggests that members of all three subfamilies 
should share similar folds, as well as similar active sites. 
This is based on the fact that many of the residues within 
the core of the I~ sandwich and in the helices facing the 
central 13 sandwich (~3 and ~4) are conserved. More im- 
portantly, nearly all of the residues that define the active 
site of CnA in this structure, both in terms of metal ion 
coordination and phosphate binding, are identical in all 
known Ser/Thr PPase sequences (P. R. C., unpublished 
data). This includes the sequence G NHE/D (residues 149- 
152 in CnA), which is present in all homologous Ser/Thr 
PPase sequences as well as in a number of phosphoester- 
ase sequences (Zhuo et al., 1994). This sequence in CnA 
includes two residues (Asn-150 and His-151) that form part 
of the active site and one residue (Glu-152) that makes a 
pair of backbone hydrogen bonds around Asp-118, the 
bridging ligand to the active site metals. 
The likelihood of structural similarity between these sub- 
families of the Ser/Thr PPases is further supported by a 
comparison of the CnA active site residues with the results 
of mutagenesis tudies carried out on the Ser/Thr PPase 
from bacteriophage X (X-PPase). This study found that 
conservative mutations in X-PPase of residues corre- 
sponding to Asp-90, His-92, and Asp-118 in CnA, all in- 
volved in metal coordination, resulted in a 106-fold de- 
crease in Koa~ (Zhuo et al., 1994). Additionally, mutation 
of His-76 in X-PPase (His-151 in CnA) led to a 10%fold 
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decrease in K~at, indicating that this residue is critical for 
enzymatic activity. 
Based on the high sequence conservation of all Ser/Thr 
PPases of the PP1, PP2A, and PP2B subfamilies in the 
vicinity of the active site, the elucidation of residues that 
are important for catalysis based on the X-PPase studies, 
and the pattern of metal ion coordination in the active site 
in our structure, one can speculate on a plausible mecha- 
nism for the phosphatase activity of CnA and related Ser/ 
Thr PPases. A water or OH- group, acting as a bridging 
ligand between Zn 2÷ and Fe 3÷, would be within 2.9 ,~. of the 
phosphorous and directly in line with the P-O scissile bond 
of the substrate (Figure 4). This ligand could act as a nu- 
cleophile and attack the phosphorous via an SN2 mecha- 
nism, leading to a pentacoordinate transition state struc- 
ture, which would be stabilized by phosphate oxygen 
contacts to Asn-150 (N51), Arg-122 (NH2), and Arg-254 
(NH2). His-151, stabilized by a salt bridge to Asp-121 and 
2.8 ,~. from the probable leaving oxygen, would then be in 
position to donate a proton to the leaving Ser side chain. 
Such a mechanism is consistent with the preferred orienta- 
tion of attacking and leaving groups for an SN2-type reac- 
tion and with the results of mechanistic studies on CaM 
and PAP that suggest that dephosporylation of substrate 
occurs with net inversion of configuration and without 
formation of a phosphoenzyme intermediate (Martin and 
Graves, 1994; Mueller et al., 1993). 
Interaction of FKBP12-FK506 with Calcineurin 
The ternary complex structure provides atomic level de- 
tails of the specific interactions that make FK506 an effec- 
tive calcineurin inhibitor and immunosuppressant. It also 
demonstrates that the composite surface of the FKBP12- 
FK506 complex is critical for calcineurin recognition and 
binding. This is seen clearly in Figure 8, which shows the 
FKBP12-FKS06 contact surface color coded as a function 
of distance to calcineurin atoms. There are no major con- 
formational changes in the FKBP12-FK506 binary com- 
plex upon binding to calcineurin, as might be expected 
from a comparison of the FKBP12 native (Wilson et al., 
1995), FKBP12-FKS06 (van Duyne et al., 1991a, 1993; 
Becker et al., 1993; Wilson et al., 1995), and FKBP12- 
rapamycin (van Duyne et al., 1991b, 1993; Wilson et al., 
1995) complexes. There are, however, subtle but signifi- 
cant changes scattered throughout FKBP12 at the cal- 
cineurin interface. These changes occur in backbone as 
well as side chain atoms. The backbone His-87 to lie-90 
loop of FKBP 12, for example, shifts by about 1 .~. on contact 
with CnA; in turn, the critical lie-90 residue (Yang et al., 
1993; Futer et al., 1995) adopts a different side chain con- 
formation. The flexibility of this particular loop has been 
noted in the native and binary complex structures (Wilson 
et al., 1995) and in the structures of FK506 complexes 
with effector surface mutants of FKBP12 (Itoh et al., 1995; 
S. Itoh and M. A. N., unpublished data) and FKBP13 
(J. P. G. et al., unpublished data). It is possible that some 
of this flexibility is necessary to optimize complementarity 
between the calcineurin and binary complex effector sur- 
faces (see Figure 8). An in-depth analysis of FKBP muta- 
genesis studies in the context of the calcineurin structure 
will be discussed elsewhere. 
Based on the properties of FK506 analogs, it has been 
proposed that the ligand contacts caicineurin through 
three distinct regions: the C29-C34 cyclohexyl moiety, the 
C21 allyl region, and the C15-C18 region (Figure 1). As 
in the case with site-directed mutants of FKBP12, chemical 
modification (Goulet et al., 1994) of FK506 in these regions 
can dramatically decrease calcineurin inhibitory activity. 
Conversely, other regions of the ligand can tolerate more 
radical changes without compromising potency. For ex- 
ample, significant modifications to the cyclohexyl ring and 
its substituents have little or no effect on binding to 
FKBP12, and several analogs of this class are still potent 
inhibitors of calcineurin (Goulet et al., 1994). This is clearly 
explained by the ternary complex structure, which shows 
that the the cyclohexyl moiety is partially exposed to sol- 
vent and seems to lack tight, specific contacts with cal- 
cineurin. On the other hand, even slight modifications of 
the C21 allyl group of FK506 can significantly reduce the 
calcineurin inhibitory potential of the FKBP12 complexes 
with the resultant analogs. In the case of the immunosup- 
pressive FK506 analog ascomycin, for example, trunca- 
tion of the C21 allyl group to ethyl leads to a 20-fold reduc- 
tion of calcineurin binding; elongation of this substituent 
effectively eliminates binding (Sigal and Dumont, 1992; 
Goulet et al., 1994). A cursory examination of the crystal 
structure of the ternary complex shows the C21 allyl of 
FK506 packed tightly in a hydrophobic binding pocket 
whose size suggests that a three-carbon substituent at 
that position would be optimal. The structure also suggests 
an explanation for the loss of activity associated with the 
18-hydroxy ascomycin analog L-685,818 (Becker et al., 
1993), since it indicates that either the R or S substitution 
would place the 18-hydroxy group in an unfavorable hy- 
drophobic environment. A comprehensive analysis of the 
possible consequences on the ternary complex of known 
FK506 analogs will be discussed in detail 
Inhibition of Calcineurin by FKBP12-FK506 
In the ternary complex structure, FK506 is located 25 ,~ 
from the phosphatase active site and, as such, does not 
participate directly in calcineurin phosphatase inhibition. 
Instead, FK506 mediates calcineurin phosphatase inhibi- 
tion and the immunosuppression that follows by forming 
a co~nposite ffector surface with structural elements from 
FKBP12, which then recognize and bind tightly to cal- 
cineurin. It is the bound FKBP12 that physically blocks 
access by NF-ATp (and possibly other macromolecular 
substrates) to the calcineurin phosphatase active site, not 
by a direct interaction with that site, but by virtue of its 
eclipsing position relative to it. It should be noted that the 
bound FKBP12 is no closer than 10 ,~. from the phospha- 
tase site (Figure 2). This mode of inhibition is consistent 
with studies on calcineurin inhibition by FKBP12-FK506 
that demonstrated that the dephosphorylation of a 20 resi- 
due phosphopeptide by calcineurin is strongly inhibited 
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by FKBP12-FK506, whereas dephosphorylation of p-nitro- 
phenyl phosphate is actually increased by a factor of 3 (Liu 
et al., 1991). 
It is interesting to speculate, based on the structure of the 
calcineurin-FKBP12-FK506 complex, about the nature of 
the interaction between calcineurin and the immunosup- 
pressive CyP-CsA complex. At least three sets of experi- 
mental results suggest that FKBP12-FK506 andCyP-CsA 
complexes bind to similar a region of calcineurin. One result 
shows that he two immunophilin-ligand complexes com- 
pete for binding to calcineurin (Liu et al., 1991), suggesting 
that their binding sites at least partially overlap. Secondly, 
mutations in the latch region of CnB, residues 118-124, 
lead to loss of inhibition by CyP-CsA (Milan et al., 1994). In 
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Figure 7. FK506 Binding 
(A) FK506 (shown in white) complexed to FKBP12 (shown in red) and to both CnA (shown in blue) and CnB (shown in green) in the ternary complex. 
The allyl group of FK506 (see Figure 1 for schematic) is embedded in a hydrophobic environment composed of Leu-115, Met-118, Val-119, and 
of Leu-123 from CnB and of Leu-343, Pro-344, Trp-352, Ser-353 (C~), and Phe-356 from CnA. 
(B) Conformation of FK506. Compared with what is seen in the binary structure (Wilson et al., 1995), shown in yellow, FK506 (shown in white) is 
rotated by approximately 8° in the ternary complex. This results in a displacement of 1.7 ,A for the C21 carbon at the base of the allyl group. The 
backbone atoms of FKBP12 are used for superposition. 
(C) Superposition of rapamycin (shown in yellow). Coordinate superposition used the molecular similarity option in the program QUANTA (Molecular 
Simulations). Interpenetration of the effector domain of rapamycin into calcineu rin clearly explains lack ef FKBP 12-rapamycin binding to calcineurin. 
the structure presented here, two thirds of the total surface 
area contact between CnB and the FKBP12-FK506 com- 
plex comes from this latch region, suggesting that both 
immunophilins bind to similar regions of CnB. Finally, CnA 
mutation of Leu-312, which is in loop L7, also results in 
CsA resistance. The L7 loop of CnA is in close proximity 
to the FKBP12-FK506 complex in the ternary structure, 
again suggesting that CyP-CsA binds in the same general 
location. Since, from our structure, it appears that the pre- 
cise positioning of the FKBP12-FK506 complex on calci- 
neurin is not critical for blocking access of substrates to 
the active site and providing inhibition, the binding of CyP- 
CsA to a similar region of calcineurin would appear to 
inhibit he phosphatase activity of this enzyme by the same 
mechanism. 
high concentration (Aldape et al., 1992), and rapamycin 
acts as an antagonist of the immunosuppressive action 
of FK506. This lack of calcineurin inhibitory activity can be 
explained by a superimposition of the FKBP12-rapamycin 
binary complex structure (Wilson et al., 1995) on the struc- 
ture of FKBP12-FK506 seen in the calcineurin ternary 
complex. As seen in Figure 7, if FKBP12-rapamycin were 
to bind the calcineurin complex, the larger "effector do- 
main" region of rapamycin relative to FK506 (Figure 1) 
would then interpenetrate the backbone of CnB at resi- 
dues 118-119 as well as the side chains of Phe-356 and 
Lys-3~60 in the BBH of CnA. In addition to those steric 
violations, rapamycin lacks an equivalent o the C21 allyl 
in FK506 and would not be able to participate in key hy- 
drophobic interactions with CnA and CnB. 
The FKBP12-Rapamycin Complex Does Not 
Inhibit Calcineurin 
The peptidyl prolyl isomerase activity of FKBP12 is also 
potently inhibited by rapamycin (Vezina et al., 1987), a 
natural product isolate that is an immunosuppressant by a 
mechanism that does not involve calcineurin inhibition (Du- 
mont et al., 1992; Bierer et al., 1990). In fact, the FKBP12- 
rapamycin complex does not inhibit calcineurin, even at 
CaM Binding and AIDs 
In addition to the phosphatase and CnB-binding domains, 
CnA also possess a CaM-binding domain (Kincaid et al., 
1988) and a C-terminal AID (Hashimoto et al., 1990); the 
latter two elements are not present in the structure de- 
scribed here. Considerable biochemical, mutagenic, and 
kinetic data have been accumulated with respect to the 
activity of these domains, however, and these data can 
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Figure 8. Interaction between the FKBP12- 
FK506 Complex and Calcineurin 
The molecular surface of the FKBP12-FK506 
complex is color coded according to its dis- 
tance from CnA and CnB, ranging from blue 
(d > 10 ,a,) to white (d = 6 ,~,) to red (<3.5 ,~). 
In the ternary complex, there are extensive in- 
teractions between calcineurin and both 
FKBP12 and FK506. The figure was produced 
using GRASP (Nicholls et al., 1991). The view 
on the right is rotated by 90 ° . 
now be reexamined in light of the structure of the cal-. 
cineurin ternary complex presented here, to'provide a 
clearer understanding of the Ca2+/CaM-modulated regula- 
tion of calcineurin. 
A minimal inhibitory peptide within the AID has been 
delineated to a stretch of about 25 residues (457-482) 
near the the C-terminus of CnA (Perrino et al., 1995). When 
this region is removed, CnA becomes a Ca2+-independent 
phosphatase whose interaction with FKBP12-FK506 also 
becomes Ca2+/CaM independent (O'Keefe et al., 1992). 
Moreover, preliminary results suggest that an isolated 
AID synthetic peptide added to the calcineurin-FKBP12- 
FK506 complex can inhibit he activity of the phosphatase 
toward small substrates (J. A. T., unpublished ata). Taken 
together, this evidence suggests that the AID binds at or 
very near the active site of CnA and that its covalent attach- 
ment to the rest of CnA is a necessary element for Ca2+/ 
CaM modulation of the enzyme. Based on this information 
and on the structure presented here, a plausible model 
for the autoregulation of calcineurin can be proposed. In 
this model, the CaM-binding domain, which is predicted 
to be an amphipathic a helix (Kincaid et al., 1988), would 
lie underneath the BBH, held at one end by a link to the 
C-terminus of the BBH and on the other by a link to the AID. 
Such an arrangement would place the AID in the immediate 
vicinity of the active site, where it would be able to exert 
its autoinhibitory function. In this model, the CaM-binding 
helix and perhaps the AID would block access by 
FKBP12-FK506 to its binding site on CnB-BBH in the 
absence of Ca2+/CaM. When Ca 2÷ and CaM are added 
to the system, the activated CaM could then bind to the 
CaM-binding helix in a manner similar to that depicted in 
Figure 6 and would disrupt its interaction with the BBH. 
This would simultaneously remove the AID from the active 
site, and in this condition, both phosphorylated substrates 
and FKBP12-FK506 would enjoy access to their binding 
sites on calcineurin. 
Myristylation of CnB 
Protein N-myristylation has been previously reviewed 
(Gordon et al., 1991 ; Resh, 1994). It is a largely irreversible 
posttranslational modification that is strictly dependent on 
the presence of an N-terminal glycine residue to accept 
the direct coupling of the 14-carbon myristic acid moiety; 
other sequence motifs may also be present to determine 
the specifity of this reaction. Protein myristylation can have 
varied consequences with respect to the function of the 
modified protein. Perhaps the most dramatic of these is 
exemplified by the myristoylated Ca2+-binding protein re- 
coverin (a member of the EF hand superfamily of Ca 2+- 
binding proteins and a close relative of CnB), in which Ca 2+ 
binding acts as a switch, leading to the extrusion of myristate 
and binding of the protein to membrane (Flaherty et al., 1993; 
Ames et al., 1995). An alternative view would consider the 
myristate posttranslational substituent as simply another 
constitutent of the structure of CnB that might lead directly 
to a stabilization of the protein, as shown in the stabilization 
of recombinant cAMP-dependent protein kinase as a result 
of its myristylation (Yonemoto et al., 1993). 
Conclusion 
The immediate mechanism of calcineudn phosphatase in- 
hibition by FK506 that leads to imunosuppression has now 
been delineated by the structure of the ternary complex 
presented here. It is striking that the FKBP12-FK506 com- 
plex exerts its inhibitory effects on calcineurin at a position 
that is distant from the active site. Our structure strongly 
reinforces existing biochemical evidence that the FKBP12- 
FK506 binary complex inhibits calcineurin phosphatase 
activity without a direct active site interaction. Instead, its 
physical presence on calcineurin blocks access to the 
phosphatase active site by macromolecular phosphory- 
lated substrates such as the NF-ATp transcription factor. 
The structure of CnA described here also provides insights 
into the structures and mechanisms of a broad family of 
Ser/Thr PPases, many of which are involved in aspects 
of cellular regulation. The structural information presented 
here should be invaluable in the design of specific experi- 
ments to explore the therapeutic potential of inhibitors of 
this and related enzymes. 
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Table 1. Data Collection and Phasing Statistics for Ternary Complex 
Statistic Native 1 PIP Pb(NO3)2 Native 2 HgCI2 Pb(NO3)2 K2PtCI4 
Resolution (,&,) 3.00 3.70 3.50 2.30 3.20 2.80 2.80 
Unique reflections 18,3332.9 10,414 11,940 41,097 16,426 24,794 24,413 
Redundancy 2.9 3.4 4.6 3.0 3.0 3.6 3.2 
Completeness (%) 90.9 95.0 94.3 91.3 96.9 97.5 97.1 
R~ym (%) 8.4 8.7 8.2 5.0 7.5 6.3 5.9 
Unit cell dimensions 
a (,~) 89.3 89.3 89.3 90.1 89.6 89.7 90.1 
b (~) 92.1 92.0 91.9 94.4 94.1 95.5 93.6 
c (A) 118.5 118.5 118.0 116.8 117.1 117.0 116.8 
MIR Analysis 
Resolution (,&,) 
4.6 4.6 4.6 3.3 3.3 3.3 3.3 
R~,o (%) 11.3 9.0 11.1 9.1 8.7 
Number of sites 2 4 3 3 3 
Phasing power t .46 1.95 1.04 1.19 1.11 
Rc 0.63 0.58 0.71 0.71 0.70 
Mean overall figure of merit 0.53 0.58 
Refinement Statistics (Native 2) 
Resolution (,~) 
3.93 3.28 2.92 2.68 2.50 Total 
R factor (%) 16.9 22.1 25.5 27.8 29.9 22.0 
Rf,~e (%) 26.3 33.7 36.8 37.0 38.3 32.8 
Reflections (IFI>I.5~IFt) 5809 5662 5440 5100 4641 26,652 
Total number of atoms 4982 
rms bond length (,&,) 0.020 
rms bond angle (degrees) 3.77 
All heavy atom soaks along with tranfers to cryoprotectants were done at 4°C. Native 1, PIP, and Pb(NO3)2 (first set) data were- collected from 
crystals stabilized in 50 mM HEPES (pH 7.5) and 12% PEG 8000. Crystals were transferred to 50 mM HEPES (pH 7.5), 12% PEG 8000, and 
22% glycerol before flash freezing for data collection. Native 2, HgCI2, Pb(NO3)2 (second set), and K2PtCI4 data were collected from crystals stabilized 
in 0.1 M potassium phosphate (pH 7.5) and 12% PEG 8000 and cryoprotected in 0.1 M potassium phosphate (pH 7.5), 9% PEG 8000, and 23% 
ethylene glycol. All data sets were collected on a Rigaku R-Axis I Ic imaging plate area detector. R~ym = Ell - <I>I/T-,I, where I = observed intensity, 
<1> = average intensity obtained from multiple observations of symmetry related reflections. Riso = Z:IIFp. - IFPII/~IFPI, where IFpI = protein 
structure factor amplitude, IFp.I = heavy-atom derivative structure factor amplitude. Phasing power = rms (IFHI/E), where IF.I = heavy-atom 
structure factor amplitude, and E = residual lack of closure. 
Experimental Procedures 
Sample Preparation and Crystallization 
A crude population of mixed isozymes of bovine calcineurin was iso- 
lated from calf brains (1 year old or less), as described by Sharma 
and Wang (1986). The remaining noncalcineurin contaminants were 
removed by anion exchange chromatography using DEAE-Sepharose 
(Pharmacia) equilibrated in 20 mM Tris-HCI, 2 mM I~-mercaptoethanel, 
1 mM magnesium acetate, 1 mM imidazele, 0.1 mM EGTA, 0.t mM 
PMSF (pH 7.6) at 4°C. Proteins were eluted with a linear gradient of 
0-300 mM NaCI (10 column volumes) in the same buffer system at 
4°C. Calcineurin, which eluted as the main peak, was then fractionated 
into numerous isoforms by hydrophobic interaction chromatography. 
Protein was exchanged into a buffer consisting of 50 mM Tris-HCI, 
1.4 M ammonium sulfate, 5% (v/v) glycerol, 2 mM 13-mercaptoethanol, 
1 mM EGTA (pH 7.5) at 20°C and loaded onto a Hydropore-HIC (Rai- 
nin) column (2.0 cm x 30 cm) equilibrated in the same buffer. The 
calcineurin isozymes were etuted at 20°C with a linear gradient (8 
column volumes) from 1.4 M to 0 M ammonium sulfate, keeping the 
other buffer parameters constant. The first peak, which represented 
about 60% of the total protein, was concentrated and dialyzed into 
25 mM Tris-HCI, 0.1 mM MnCI2, 0.1 mM CaCI2, 2 mM 13-mercapto- 
ethanol (pH 8.0) at 4°C. 
A binary complex of recombinant bovine FKBP12 and FK506 was 
prepared, as described previously (Wilson et al., t995). This was dia- 
lyzed into 25 mM Tris-HCI, 0.1 mM MnCI2, 0.1 mM CaCI2, 2 mM 
~-mercaptoethanol (pH 8.0) at 4°C and then combined with the pure 
calcineurin at a 1:1.3 molar ratio (calcineurin:FKBP12-FK506 com- 
plex) and a final total protein concentration of 1-2 mg/ml. The cal- 
cineurin-FKBP12-FK506 complex was allowed to equilibrate for 1 hr 
at 4°C before the addition of Clostripain (IUB 4.4.22.8, Worthington) 
at 3 mg per 100 mg of complex. Proteolytic digestion of the complex 
was allowed to proceed for 3-4 days at 4°C before being concentrated 
to 15-20 mg/ml (50-100 mg of total protein) and then size fractionated 
at 4°C on a column system of Sephacryl S-300 HR (2.6 cm x 100 
cm x 3 cm) equilibrated in the same buffer. The main peak, which 
eluted soon after the void volume, consisted of the intact complex, 
containing truncated calcineurin (43 kDa A chain, unmodified B chain), 
FKBP12, and FK506. Clostripain and unbound FKBP12-FK506 eluted 
later. The complex was concentrated by ultrafiltration to 25-55 mg/ 
ml and centrifuged at 40,000 x g for 10-15 min. 
Crystals were obtained from these solutions, using hanging drops 
(initially 8 #.1 total, 25% precipitant) suspended over a precipitant reser- 
voir of 8% PEG 8000, 0.1 M potassium phosphate, 20 mM 13-mercap- 
toethanol. Crystals appeared within 3-4 days at 4°C and reached 
maximal size in about 2-3 weeks. They belong to space group P21212~ 
with unit cell dimensions a = 90.3 ,~, b = 97.6 ,~,, and c = 117.8 ,~ 
and one ternary complex per asymmetric unit. SDS-PAGE analysis 
of redissolved crystals showed the protein composition was indistin- 
guishable from that found in the mother liquor. Complete details con- 
cerning the purification and characterization of the calcineurin, ternary 
complex formation, in vitro proteolysis, and crystallization and charac- 
terization of the truncated complex will be presented elsewhere (J. A. 
T. et al., unpublished data). 
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Data Collection and Processing 
Structural data are summarized in Table 1. Initial heavy atom searches 
were carried out with crystals stabilized in 50 mM HEPES (pH 7.5) 
and 12% PEG 8000 to remove phosphate during the heavy atom soaks 
and to help stabilize the ~-axis length, which varied by up to 4 ,~, be- 
tween native crystals in phosphate buffer. This stabilization and subse- 
quent cryoprotection in solutions containing 50 mM HEPES (pH 7.5), 
12% PEG 8000, and 220/0 (w/v) glycerol chang=ed the unit cell dimen- 
sions to a = 89.3 ,~, b = 92.1/~, and c = 118.5 A. Two derivatives were 
obtained under these conditions using platinioiodoplatinate (PIP) and 
Pb(NO3)2, the latter on crystals that had been pretreated with EGTA 
to remove Ca 2. from the metal-binding sites on CnB (Table 1). All data 
sets were collected from crystals frozen and maintained at -165°C 
in a dry nitrogen gas stream (Molecular Structure Incorporated). Data 
were acquired by oscillation photography on a Rigaku R-AXIS IIC phos- 
phorimaging area detector mounted on a Rigaku RU200 rotating 
anode generator (Molecular Structure Incorporated), operating at 50 
kV and 100 mA. Measured intensitJes were integrated, scaled, and 
merged using the HKL software package (Z. Otwinowski and W. Minor, 
personal communication). 
Phasing, Model Building, and Refinement 
Heavy atom positions were located by inspection or with RSPS (Collab- 
orative Computation Project, 1994) and confirmed with cliff?fence Fou-. 
tier syntheses. Heavy atom parameters were refined with HEAVY (Ter- 
williger and Eisenberg, 1983) and phases were computed using either 
HEAVY or MLPHARE (Otwinowski, 1991). MIR phases were improved 
and extended by cycles of solvent flattening (Wang, 1985), phase com- 
bination (Reed, 1986), and, when appropriate, histogram matching com- 
bined with Sayre's equation (Zhang and Main, 1990) within the CCP4 
crystallographic package. The molecular model was built into electron 
density maps using QUANTA 4.1 (Molecular Simulations, Burlington, 
MA) and the model refined with X-PLOR 3.1 (Br(Jnger, 1993). Refine- 
ment of the PIP and Pb(NO3)2 derivatives, including the anomalous 
contribution from the lead, gave a figure of merit of 0.53 for data to 
4.6 A. The resulting MIRAS map was subjected to cycles of solvent 
flattening, phase combination, and phase extension to produce an 
electron density map at 4.0 ~,. A partial model for CnA and CnB could 
readily be built into this map, and FKBP12 was positioned into the 
density as a rigid body. At this stage, the partial structure was refined 
against the first native data set collected (native 1) and then refined 
as a rigid body against a new native data set (native 2) collected from 
crystals stabilized in 0.1 M potassium phosphate (pH 7.5) and 12% 
PEG 8000 and cryoprotected with 0.1 M postassium phosphate (pH 
7.5), 90/0 PEG 8000, and 23% ethylene glycol. These conditions 
yielded yet another cell, with dimensions a = 91.3 ~,, b = 94.4 h,, 
and c = 116.8, but resulted in much higher resolution diffraction data. 
Three new derivatives, soaked and cryoprotected under the same 
conditions as native 2, were obtained with HgCI2, Pb(NO3)2, and 
K2PtCI4. Heavy atom parameter efinement for these threederivatives 
against native 2 gave a final figure of merit of 0.58-3.3 A, including 
the lead anomalous data. This MIRAS map was again subjected to 
cycles of solvent flattening and phase extension, and multiple electron 
density maps were calculated, ranging from 3.6 to 2.6/~ resolution. 
The resulting maps showed clear density in which approximately 80% 
of the CnA and CnB chains could be built as polyalanine, beginning 
with the previous model. Strong density was also readily apparent for 
FK506 and a putative CnA active site at this stage, but these regions 
were intentionally left unbuilt until the latter stages of model building to 
leave them as unbiased as possible. Multiple rounds of model building, 
positional refinement, phase combination, and phase extension gave 
improved electron density maps into which a nearly complete model 
of the ternary complex was built. The positions of the lead, mercury, 
and platinum heavy atoms helped to confirm the assigned sequence 
register during building of loops and side chains in the final stages. 
A nearly complete ternary complex model was subjected to simulated 
annealing refinement from 3000 K to 200 K at 2.8 ,~ resolution followed 
by positional refinement. The remaining loops and side chains, along 
with FK506 and well-ordered water molecules, were built into 21Fo I - 
JF~la~ and IFo) - IF~ja~ difference Fourier maps. The current model 
contains residues 24-370 of CnA (excluding residues 241-246, which 
are presumed disordered); residues 1-168 of CnB, including an N-ter- 
minal myristoyl group; FKBP12-FK506; four Ca 2+ ions in the CnB Ca ~*- 
binding sites; one phosphate, one Fe 3+ ion, and one Zn 2÷ ion in the 
CnA active site; and 87 water molecules. The current R factor for data 
between 6.0 and 2.5 ,~ (29657 reflections with IFI > 1.5 o(F)) is 22.0%, 
and the free R factor IBr(Jnger, 1992) is 32.80/0. The rms deviation 
from ideality is 0.020 A for bond lengths and 3.8 ° for bond angles, 
with good sterecchemistry for backbone torsion angles. 
Superimposition of Rapamycin 
The FKBP12-rapamycin structure (at 1.7 ,~,, R = 18.1% ; Wilson et 
al., 1995) was superimposed on the FKBP12 in the ternary structure 
using 428 backbone atoms within the rigid-body fit option QUANTA 
4.1. The backbone atoms superimposed with 0.9 Arms deviations. 
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